BridgeMD
New treatment option for Delirium, Postoperative
Official title Reducing Delirium After CABG Surgery With Early Activation and Sleep-Promoting Routines
ClinicalTrials.gov ID: NCT06107517
What this study is testing
- What it's testing
- The goal of this randomized-controlled trial (RCT) is to compare the effectiveness of the DREAMS-OT intervention with standard care in reducing post-Coronary Artery Bypass Graft (CABG) surgery delirium in patients undergoing CABG surgery. The aims of the study are: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 99
You may be able to join if
- Patients deemed medically suitable for elective CABG surgery
- Patients aged 21 years and above
- Patients who are English or Mandarin speaking.
- Patients who are able to provide consent
You likely can't join if
- Patients who speak other languages are excluded due to the language requirements of certain outcome measures.
- Patients with premorbid severe hearing impairment, severe cognitive impairment, progressive neurological disorders and psychological disorders will...
- Patients with surgical complications resulting in profuse bleeding from any invasive sites, septic shock unresponsive to maximal treatment, and those...
- Pregnant women will also be excluded from the study as well.
- Patients who develop delirium before initiation of the treatment are also excluded from the study.
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.